Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 November 2020 | Story Thabo Kessah | Photo Thabo Kessah
Prof Pearl Sithole acknowledged the role played by the Afromontane Research Unit in securing mountain-to-mountain research funding from the US Embassy and Consulates in SA.

“This launch is an opportunity to reflect on the strategic significance of the partnership between our two universities and the long-standing relationship that academics at the two institutions have enjoyed.” 

These were the words of appreciation from the University of the Free State Vice-Rector: Research, Innovation and Internationalisation, Prof Corli Witthuhn, during the virtual launch of the Mountain-to-Mountain collaboration project between the University of the Free State and the Appalachian State University in the United States held on 10 November 2020. The R8 million project is funded by the US Embassy and Consulates in South Africa and will run over two academic years.

Prof Witthuhn also stated that the project would further strengthen the UFS strategy for internationalisation. “This collaboration has grown organically in the last decade to become one of the UFS flagships in international collaborations. With the support of this grant from the US Embassy and Consulates in South Africa, this long-standing and sustainable collaboration will be further strengthened,” she added.

New master’s programmes

In providing context to the Qwaqwa Campus’ research footprint, Campus Vice-Principal: Academic and Research, Prof Pearl Sithole, acknowledged the role played by the Afromontane Research Unit (ARU) under the leadership of its Director, Dr Ralph Clark, as well as all the faculties.

“In the Humanities, a lot is coming regarding the socio-ecosystems of the mountains. And in Education and Economic and Management Sciences, the scholarship of teaching and learning is promoted through blended skills, especially during this time of the pandemic. In the Natural and Agricultural Sciences, climate monitoring is one of the projects that has brought vibrancy to our campus,” she said.

Appalachian State University’s Associate Vice-Chancellor for International Education and Development, Prof Jesse Lutabingwa, mentioned that the collaboration would, among others, develop and offer a multi-disciplinary master’s degree in Mountain Studies on the Qwaqwa Campus, which will initially enrol seven to ten students. “In the subsequent years, we plan to increase this number to 15-20 students. We will also develop and offer a Community Development master’s degree with 10-12 students and up to 25 in subsequent years.”

Black women academics

Prof Lutabingwa, who is also the Project Director, revealed that doctoral students who are currently part of the University Staff Doctoral Project (USDP), will conduct at least three research projects focusing on social entrepreneurship, substance abuse, and rural transport monitoring in the Maloti-Drakensberg Mountains. “Also key to this collaboration is the leadership mentorship programme for black women academics who will at the end of the project produce three to five research papers,” Prof Lutabingwa added.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept